title: In vitro antimycobacterial activities of Physalis angulata L.
abstract: The HIV-tuberculosis co-infection has caused an impact on tuberculosis epidemiology all over the world and the efficacies of the therapeutic schemes traditionally prescribed in the treatment of tuberculosis, such as isoniazid, rifampicin and pyrazinamide, have decreased due to the appearance of multidrug-resistant M. tuberculosis strains (MDR). This work is part of research on natural antimicrobial agents from plant extracts through bioassay-guided fractionation, by in vitro determination of the minimum inhibitory concentration (MIC) using the microdilution method with Alamar blue oxidation-reduction dye. Crude CHCl3 Physalis angulata extracts and physalin-containing fractions displayed antimycobacterial activity against Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium kansasii, Mycobacterium malmoense and Mycobacterium intracellulare.
authors.affiliation: Departamento de Ciências Farmacêuticas, Universidade de Ribeirão Preto - UNAERP Ribeiräo Preto, SP Brasil. rpietro@online.unaerp.br
authors.forename: R C
authors.initials: RC
authors.lastname: Pietro
authors.forename: S
authors.initials: S
authors.lastname: Kashima
authors.forename: D N
authors.initials: DN
authors.lastname: Sato
authors.forename: A H
authors.initials: AH
authors.lastname: Januário
authors.forename: S C
authors.initials: SC
authors.lastname: França
mesh_terms: D006801:Humans; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects*; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use; D010946:Plants, Medicinal; D019657:Solanaceae; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D010936:Plant Extracts